Jazz Pharmaceuticals plc
JAZZ
$138.81
$2.361.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 35.02% | 479.28% | 556.49% | 311.66% | 285.14% |
| Total Depreciation and Amortization | 3.35% | 4.27% | 6.17% | 6.19% | 1.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.92% | -56.66% | -71.54% | -73.45% | -71.64% |
| Change in Net Operating Assets | 62.47% | -602.32% | -235.71% | -341.39% | -2,164.00% |
| Cash from Operations | 27.83% | -8.05% | -22.09% | -24.95% | -14.15% |
| Capital Expenditure | -58.88% | -50.12% | -102.29% | -31.43% | 17.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -237.98% | 68.51% | -44.61% | 9.66% | 70.42% |
| Cash from Investing | -211.66% | 63.83% | -46.59% | -3.96% | 63.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,854.84% | -1,854.84% | 90.63% | 90.63% | 94.67% |
| Issuance of Common Stock | -55.56% | -70.04% | -69.11% | -73.62% | -52.60% |
| Repurchase of Common Stock | -15.11% | -110.07% | -163.59% | -494.22% | -604.91% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 106.72% | 61.42% | -0.13% | -15.10% | 42.35% |
| Foreign Exchange rate Adjustments | -247.32% | -43.89% | -1,046.26% | 79.74% | 118.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.09% | 77.79% | -87.13% | -59.31% | 115.43% |
